VNDA icon

Vanda Pharmaceuticals
VNDA

Overview Fund Activity

141 hedge funds and large institutions have $648M invested in Vanda Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 63 increasing their positions, 48 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+1
Holders Change %
+0.71%
% of All Funds
3.53%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
19
Increased
63
Reduced
48
Closed
15
Calls
$15M
Puts
$13.6M
Net Calls
+$1.33M
Net Calls Change
-$8.42M

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$21.9M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$15.9M
3
BFA
3
BlackRock Fund Advisors
California
$36.2M
4
Invesco
4
Invesco
Georgia
$7.78M
5
NI
5
Numeric Investors
Massachusetts
$7.92M

Top Sellers

1
PC
1
Paulson & Co
New York
$0
2
GPP
2
Great Point Partners
Connecticut
$32.1M
3
Millennium Management
3
Millennium Management
New York
$16.3M
4
ACA
4
Avoro Capital Advisors
New York
$6.08M
5
LOAMU
5
Lombard Odier Asset Management (USA)
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
151
Bridgeway Capital Management
Texas
– -$582K -35,000 Closed
Asset Management One
152
Asset Management One
Japan
– -$398K -23,905 Closed
VRS
153
Virginia Retirement Systems
Virginia
– -$361K -21,700 Closed
UBS AM
154
UBS AM
Illinois
– -$271K -16,300 Closed
DTL
155
Dynamic Technology Lab
Singapore
– -$254K -15,276 Closed
TI
156
Trexquant Investment
Connecticut
– -$185K -11,100 Closed
3 4 5 6
7